Skip to content

Clinical trials

Pulmonary Embolism trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Country / region: Canada Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20043
20052
20065
20075
20083
20093
20101
20115
20124
20131
20144
20153
20163
20175
20204
20214
20222
20233
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Terminated8
Unknown status7
Recruiting5
Active, not recruiting3
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
McMaster University10
Ottawa Hospital Research Institute9
Bayer5
Bristol-Myers Squibb5
University of Calgary4
Daiichi Sankyo3
Hamilton Health Sciences Corporation3
Sanofi3
Anthos Therapeutics, Inc.2
Dr. Kerstin de Wit2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism73
Venous Thrombosis47
Venous Thromboembolism33
Thrombosis11
Neoplasms7
Thromboembolism5
Embolism and Thrombosis4
Hemorrhage4
Lung Neoplasms4
Atrial Fibrillation3

Trials

Showing 76 to 73 of 73. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.